Audit 17392

FY End
2022-10-31
Total Expended
$3.40M
Findings
0
Programs
39
Organization: Gordon Research Conferences (RI)
Year: 2022 Accepted: 2023-03-01
Auditor: Kpmg

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
47.041 Engineering $368,950 Yes 0
47.074 Biological Sciences $276,495 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $267,337 Yes 0
81.049 Office of Science Financial Assistance Program $244,510 Yes 0
12.800 Air Force Defense Research Sciences Program $215,050 Yes 0
93.855 Allergy, Immunology and Transplantation Research $188,400 Yes 0
47.050 Geosciences $171,680 Yes 0
12.431 Basic Scientific Research $145,220 Yes 0
12.300 Basic and Applied Scientific Research $124,990 Yes 0
93.866 Aging Research $118,998 Yes 0
47.049 Mathematical and Physical Sciences $111,870 Yes 0
10.310 Agriculture and Food Research Initiative (afri) $105,000 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $99,000 Yes 0
93.173 Research Related to Deafness and Communication Disorders $91,855 Yes 0
93.865 Child Health and Human Development Extramural Research $85,000 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $75,470 Yes 0
43.001 Science $70,000 Yes 0
93.213 Research and Training in Complementary and Integrative Health $58,500 Yes 0
93.273 Alcohol Research Programs $54,876 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $50,400 Yes 0
47.075 Social, Behavioral, and Economic Sciences $50,250 Yes 0
93.242 Mental Health Research Grants $50,000 Yes 0
93.279 Drug Abuse and Addiction Research Programs $44,400 Yes 0
11.431 Climate and Atmospheric Research $40,560 Yes 0
93.837 Cardiovascular Diseases Research $40,000 Yes 0
93.121 Oral Diseases and Disorders Research $39,500 Yes 0
93.350 National Center for Advancing Translational Sciences $37,660 Yes 0
93.143 Niehs Superfund Hazardous Substances_basic Research and Education $26,000 Yes 0
93.396 Cancer Biology Research $26,000 Yes 0
93.103 Food and Drug Administration_research $25,000 Yes 0
93.839 Blood Diseases and Resources Research $20,000 Yes 0
93.393 Cancer Cause and Prevention Research $18,000 Yes 0
93.867 Vision Research $16,075 Yes 0
11.620 Science, Technology, Business And/or Education Outreach $10,200 Yes 0
93.838 Lung Diseases Research $10,000 Yes 0
93.395 Cancer Treatment Research $8,013 Yes 0
93.398 Cancer Research Manpower $6,000 Yes 0
93.113 Environmental Health $5,000 Yes 0
11.609 Measurement and Engineering Research and Standards $5,000 Yes 0

Contacts

Name Title Type
XL5ANMKWN557 Taryn Moran Auditee
4017884041 N. Brock Romano Auditor
No contacts on file

Notes to SEFA

Title: Basis of Accounting Accounting Policies: The accompanying supplementary schedule of expenditures of federal awards (the Schedule) summarizesthe expenditures of Gordon Research Conferences and subsidiary (GRC) under programs of the federalgovernment for the year ended October 31, 2022. The information in the Schedule is presented inaccordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, UniformAdministrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (UniformGuidance). Because the Schedule presents only a selected portion of the operations of GRC, it is notintended to and does not present the financial position, changes in net assets or cash flows of GRC.For purposes of the Schedule, federal awards include all grants, contracts, and similar agreements enteredinto directly between GRC and agencies and departments of the federal government. GRC did not passthrough any amounts to sub-recipients for the year ended October 31, 2022. GRC has elected not to utilizethe 10 percent de-minimis indirect cost rate allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying Schedule is presented using the accrual basis of accounting. Such expenditures are recognized following cost principles contained in the Uniform Guidance wherein certain types of expenditures are not allowable or are limited as to reimbursement when applicable.